Clearside Biomedical Inc. (CLSD) Income Statement Analysis - Revenue, Earnings & Profitability Metrics - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    Clearside Biomedical Inc.

    NASDAQ: CLSD · Real-Time Price · USD
    4.29
    -0.11 (-2.50%)
    At close: Oct 09, 2025, 3:48 PM

    Clearside Biomedical Income Statement

    Financials in USD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
    Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
    Revenue
    		 1.66M 8.23M 1.33M 29.57M
    Cost of Revenue
    		 149K 355K 204K 178K
    Gross Profit
    		 1.51M 7.87M 1.12M 29.57M
    Operating Income
    		 -28.88M -24.84M -30.28M -627K
    Interest Income
    		 1.46M 1.72M 669K n/a
    Pretax Income
    		 -34.35M -32.48M -32.95M 376K
    Net Income
    		 -34.35M -32.48M -32.95M 376K
    Selling & General & Admin
    		 11.81M 11.87M 11.77M 11.66M
    Research & Development
    		 18.59M 20.85M 19.63M 18.54M
    Other Expenses
    		 n/a n/a n/a n/a
    Operating Expenses
    		 30.4M 32.72M 31.4M 30.2M
    Interest Expense
    		 9.78M 9.36M 3.34M n/a
    Selling & Marketing Expenses
    		 n/a n/a n/a n/a
    Cost & Expenses
    		 30.55M 33.07M 31.6M 30.2M
    Income Tax Expense
    		 n/a n/a n/a n/a
    Shares Outstanding (Basic)
    		 4.92M 4.12M 4.01M 3.9M
    Shares Outstanding (Diluted)
    		 4.92M 4.12M 4.01M 3.99M
    EPS (Basic)
    		 -7.05 -7.95 -8.25 0.10
    EPS (Diluted)
    		 -7.05 -7.95 -8.25 0.09
    EBITDA
    		 -24.35M -23.06M -29.46M 554K
    EBIT
    		 -24.57M -23.13M -29.61M 376K
    Depreciation & Amortization
    		 226K 67K 145K 178K

    Add to Watchlist